My cravings have calmed down completely and I just naturally eat less now. Very happy with the quality.
Piero L. Verified Purchase
4.6 10 reviews

Semaglutide

The GLP-1 peptide studied for weight loss and appetite control.

  • Mimics GLP-1, a hormone the body releases after eating
  • Adults lost 14.9% of their body weight in 68 weeks
  • Also studied for heart and kidney health
Price range: £25,00 through £60,00
Bacteriostatic water 2ml vial FREE
1 free BAC water with every vial Worth £8 a bottle. Added automatically.
In Stock - Ships within 24h
How to use Semaglutide Our own 17-step illustrated guide, from mixing to storage.
My cravings have calmed down completely and I just naturally eat less now. Very happy with the quality.
Piero L. Verified Purchase
Description

What Is Semaglutide?

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that has transformed the weight management landscape since its development. Originally created for type 2 diabetes management, semaglutide works by mimicking the naturally occurring GLP-1 hormone – a key signalling molecule that your body produces after eating.

When administered, semaglutide binds to GLP-1 receptors in the brain’s appetite control centres, specifically the hypothalamus. This triggers a cascade of effects: reduced hunger signals, increased feelings of satiety after smaller meals, and slowed gastric emptying that keeps you feeling full for longer periods between meals.

How Does Semaglutide Work for Weight Loss?

Unlike traditional diet supplements that rely on stimulants or thermogenics, semaglutide addresses weight management at the hormonal level. It works through three primary mechanisms:

  • Appetite suppression: Directly reduces hunger by acting on brain receptors that control food intake and cravings, making it significantly easier to maintain a caloric deficit without constant willpower battles.
  • Delayed gastric emptying: Slows the rate at which food leaves your stomach, extending the feeling of fullness after each meal and naturally reducing portion sizes.
  • Blood sugar regulation: Enhances insulin secretion in response to meals while suppressing glucagon release, helping to stabilise blood sugar levels and reduce the energy crashes that drive snacking.

What Does the Research Say?

Semaglutide is one of the most extensively studied peptides for weight management. The landmark STEP clinical trial programme, involving over 4,500 participants, demonstrated an average body weight reduction of 12-15% over 68 weeks when combined with lifestyle modifications. Participants reported significantly reduced food cravings, particularly for high-fat and high-sugar foods.

Beyond weight loss, research has shown cardiovascular benefits including reduced risk of major adverse cardiovascular events, improved blood lipid profiles, and decreased systemic inflammation markers – making semaglutide a compelling option for metabolic health optimisation.

Who Is Semaglutide For?

Semaglutide is most commonly used by individuals seeking a science-backed approach to weight management who have found diet and exercise alone insufficient. It is particularly effective for those with a BMI over 27, individuals with metabolic syndrome markers, or anyone looking to break through weight loss plateaus with a hormonal rather than stimulant-based approach.

Clinical References
Once-Weekly Semaglutide in Adults with Overweight or Obesity
Wilding JPH, Batterham RL, Calanna S, et al.

N Engl J Med, 2021. PubMed →

Two-Year Effects of Semaglutide in Adults with Overweight or Obesity
Garvey WT, Batterham RL, Bhatt DL, et al.

Nat Med, 2022. PubMed →

Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
Marso SP, Bain SC, Consoli A, et al.

N Engl J Med, 2016. PubMed →

Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance
Rubino D, Abrahamsson N, Davies M, et al.

JAMA, 2021. PubMed →

Clinical References

  1. Kapitza C, Dahl K, Jacobsen JB, et al. Effects of semaglutide on beta cell function and glycaemic control in participants with type 2 diabetes: a randomised, double-blind, placebo-controlled trial. Diabetologia. 2017;60(8):1390-1399. PubMed 28526920
  2. Gabery S, Salinas CG, Paulsen SJ, et al. Semaglutide lowers body weight in rodents via distributed neural pathways. JCI Insight. 2020;5(6):e133429. PubMed 32213703
  3. Blundell J, Finlayson G, Axelsen M, et al. Effects of once-weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity. Diabetes Obes Metab. 2017;19(9):1242-1251. PubMed 28266779
  4. Friedrichsen M, Breitschaft A, Tadayon S, et al. The effect of semaglutide 2.4 mg once weekly on energy intake, appetite, control of eating, and gastric emptying in adults with obesity. Diabetes Obes Metab. 2021;23(3):754-762. PubMed 33269530
  5. Hjerpsted JB, Flint A, Brooks A, et al. Semaglutide improves postprandial glucose and lipid metabolism, and delays first-hour gastric emptying in subjects with obesity. Diabetes Obes Metab. 2018;20(3):610-619. PubMed 28941314
  6. Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021;384(11):989-1002. PubMed 33567185
  7. Davies M, Faerch L, Jeppesen OK, et al. Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial. Lancet. 2021;397(10278):971-984. PubMed 33667417
  8. Wadden TA, Bailey TS, Billings LK, et al. Effect of subcutaneous semaglutide vs placebo as an adjunct to intensive behavioral therapy on body weight in adults with overweight or obesity: the STEP 3 randomized clinical trial. JAMA. 2021;325(14):1403-1413. PubMed 33625476
  9. Rubino D, Abrahamsson N, Davies M, et al. Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: the STEP 4 randomized clinical trial. JAMA. 2021;325(14):1414-1425. PubMed 33755728
  10. Lincoff AM, Brown-Frandsen K, Colhoun HM, et al. Semaglutide and cardiovascular outcomes in obesity without diabetes. N Engl J Med. 2023;389(24):2221-2232. PubMed 37952131
  11. Kosiborod MN, Bhatta M, Davies M, et al. Semaglutide improves cardiometabolic risk factors in adults with overweight or obesity: STEP 1 and 4 exploratory analyses. Diabetes Obes Metab. 2023;25(2):468-478. PubMed 36200477
  12. Milluzzo A, Oteri V, Manuella L, et al. Effects of subcutaneous semaglutide on weight loss and inflammatory markers in adults with overweight or obesity without diabetes: a systematic review and meta-analysis. Int J Obes (Lond). 2026. doi:10.1038/s41366-026-02189-x. PubMed 42668312
Product specifications
Dosage
0.25mg – 2.4mg weekly (titrated)
Cycle
12–16 weeks
Form
5mg lyophilised powder
Purity
≥98%
Molecular formula
C₁₈₇H₂₉₁N₄₅O₅₉*
Storage
2–8°C refrigerated
Dosing guide

Category-Specific Dosing Guides

Semaglutide is administered once weekly by subcutaneous injection (an injection into the fatty tissue beneath the skin). Pick a day that suits your schedule and use the same day each week. Some people prefer evening injections before bed, particularly when starting semaglutide, to help minimize disruption from mild nausea. If you are looking to buy Semaglutide Europe, you'll typically find the same once-weekly administration schedule across clinical studies and prescribing information.

  1. 1

    Reconstitute Your Vial

    Add 2ml of bacteriostatic water to the 5mg vial to achieve a concentration of 2.5mg/ml.

    Use our peptide calculator to calculate concentration, injection volume, and the number of doses available from your vial based on your chosen protocol.

  2. 2

    Follow the Titration Schedule

    • Weeks 1–4: 0.25mg (10 units on a U-100 syringe with 2ml reconstitution)
    • Weeks 5–8: 0.5mg (20 units)
    • Weeks 9–12: 1.0mg (40 units)
    • Weeks 13+: 1.7mg–2.4mg, depending on tolerance and response.

    Starting low and increasing gradually can help reduce nausea during the first weeks of use. Most Semaglutide for sale follows the same stepwise titration approach.

  3. 3

    Store Correctly Between Doses

    Keep refrigerated at 2–8°C after reconstitution. Do not freeze. Store upright and away from light.

    Use within 28 days. Write the reconstitution date on the vial.

Maximise Your Results

Semaglutide is often used alongside changes in diet and activity levels. During periods of weight loss, protein intake is commonly set at 1.6–2.2g per kg of body weight. Many weight-loss guidelines recommend at least 150 minutes of moderate physical activity per week.

Shipping and returns

Free shipping on orders over £220.

Metabolic Protocol - Semaglutide - 4 Weeks Save £25,00

Fat loss + mitochondrial + gut repair - sema core. · 4 Weeks

Semaglutide
Semaglutide 5mg lyophilised powder
£25,00
MOTS-c
2× MOTS-c 10mg lyophilised powder
£40,00
BPC-157
3× BPC-157 5mg lyophilised powder
£60,00

Adults lost 14.9% of their body weight in 68 weeks

In a trial of 1,961 adults, semaglutide cut body weight by 14.9%, against 2.4% on placebo.

Weight loss - 1,961 adults

Half lost 15% or more of their body weight

Placebo4.9%
Semaglutide50.5%

In the STEP 1 trial, 50.5% of adults on semaglutide lost 15% or more of their body weight. On placebo it was 4.9%. Both groups also followed a lifestyle programme for 68 weeks.

Wilding et al., New England Journal of Medicine, 2021
Heart
17,604 adults - 39.8-month study

20% lower risk of major heart events

In adults aged 45+ with heart disease and no diabetes, 6.5% had a heart attack, stroke or cardiovascular death on semaglutide. On placebo it was 8.0%.

Lincoff et al., New England Journal of Medicine, 2023
Coaching
611 adults - 68-week trial

16.0% weight loss with diet and coaching

Adults took semaglutide with a low-calorie diet for the first 8 weeks and 30 counselling visits. They lost 16.0% of body weight, against 5.7% on placebo.

Wadden et al., JAMA, 2021

Sources: Wilding JPH et al., New England Journal of Medicine 2021;384(11):989-1002; Blundell J et al., Diabetes, Obesity and Metabolism 2017;19(9):1242-1251; Lincoff AM et al., New England Journal of Medicine 2023;389(24):2221-2232; Wadden TA et al., JAMA 2021;325(14):1403-1413

Rated 4.6 by verified buyers

Customer rating 4.6 Based on 10 reviews Write a review
March 2026

My cravings have calmed down completely and I just naturally eat less now. Very happy with the quality.

Piero L. Verified Purchase
March 2026

Third order from Morpho. Reconstitution was smooth, no clumping at all. Shipping to Germany took only 2 days.

Anna M. Verified Purchase

Leave a Review

Share your experience. Your email won't be published.

0 / 300
Photos (optional)

    Optional · up to 5 photos · JPG, PNG or WebP · max 5 MB each

    How to use Semaglutide

    Ready in 4 steps, BAC water included. A complete visual guide to preparing, reconstituting, injecting, and storing your peptides safely. Follow each step in order.

    Step 1: Supplies laid out
    1. Supplies laid out Gather your supplies: peptide vial, bacteriostatic water, syringes, alcohol swabs, cotton ball, and bandage.
    Step 2: Remove / flip caps
    2. Remove / flip caps Remove the plastic caps from both vials to expose the rubber stoppers.
    Step 3: Swab the vial stopper
    3. Swab the vial stopper Wipe the top of each vial with an alcohol swab. Let air-dry.
    Step 4: Draw BAC water
    4. Draw BAC water Draw the required amount of bacteriostatic water into the syringe. Use our calculator if unsure.
    Step 5: Inject water into vial
    5. Inject water into vial Inject the water slowly into the peptide vial, letting it run down the inside wall. Do not spray directly onto the powder.
    Step 6: Swirl to dissolve
    6. Swirl to dissolve Gently swirl the vial until the powder dissolves. Do not shake.
    Step 7: Check the solution
    7. Check the solution Check the solution: no undissolved particles, no bubbles, clear liquid. If not, wait and swirl again.
    Step 8: Draw your dose
    8. Draw your dose Draw your dose slowly from the reconstituted peptide vial.
    Step 9: Remove air bubbles
    9. Remove air bubbles Hold the syringe needle-up, flick to move air bubbles to the top, and push the plunger until a small drop appears.
    Step 10: Choose injection site
    10. Choose injection site Choose your injection site: belly fat around the navel or outer thigh. Rotate sites between injections.
    Step 11: Clean the site
    11. Clean the site Clean the injection site with an alcohol swab.
    Step 12: Pinch skin
    12. Pinch skin Pinch a fold of skin at the injection site to lift the subcutaneous fatty tissue away from the muscle.
    Step 13: Insert at 45°
    13. Insert at 45° Insert the needle at a 45° angle into the subcutaneous fatty tissue, usually approximately half the needle length. Do not inject into muscle. Inject slowly.
    Step 14: Cotton-ball press
    14. Cotton-ball press Withdraw the needle and press a cotton ball gently on the site for a few seconds.
    Step 15: Apply bandage
    15. Apply bandage Apply a small bandage.
    Step 16: Sharps disposal
    16. Sharps disposal Dispose of the needle in a sharps container.
    Step 17: Storage
    17. Storage Store reconstituted peptides in the fridge (2-8 °C). Avoid freezing and direct sunlight. Use within 90 days.

    Pre-filled for this product. Adjust values to match your protocol.

    Concentration —
    Volume Per Dose —
    Insulin Syringe Units —
    Total Doses Per Vial —
    Open full calculator

    Frequently Asked Questions

    Common questions answered